drugset / Trial / NCT01112241

Bronchodilator Responsiveness in Obliterative Bronchiolitis

NCT01112241

NaSingle-groupOpen-labelDiagnostic

Summary

This study has been designed to provide a substantial evidence of acute bronchodilator responsiveness to two sequentially inhaled drugs, a beta2-agonist (i.e., albuterol) and an anticholinergic (i.e., tiotropium bromide), in a group of patients who developed obliterative bronchiolitis after hematopoietic stem cell transplantation.

Timeline

Start
2010-04
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Salbutamol Unknown 100 ug Inhaled
Subject Tiotropium Other / unclassified 18 ug Inhaled